Zachariah McIver's most recent trade in Janux Therapeutics Inc was a trade of 91,000 Stock option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Janux Therapeutics Inc | Zachariah McIver | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 91,000 | 91,000 | - | - | Stock option (right to buy) | |
| Janux Therapeutics Inc | Zachariah McIver | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 26,000 | 26,000 | - | 0 | Common Stock |